/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Dividend appears well-covered by both earnings and free cash flow, growth streak of at least 10 years signals strong commitment.
Based on TTM and annual data · Not a buy/sell signal
Score Breakdown
Safety
40% of composite
Growth
35% of composite
Income
25% of composite
Composite = Safety (50) × 0.40 + Growth (68) × 0.35 + Income (70) × 0.25 = 61
Dividend Yield
2.18%
Per Share (TTM)
$3.22
Payout Ratio
47.0%
5Y CAGR
3.0%
Dividend Safety
Earnings Payout
47.0%
FCF Payout
31.4%
FCF Coverage
3.2x
Dividend Growth
Per Share (TTM)
$3.22
Growth Streak
10+ years
5Y CAGR
3.0%
Dividend Schedule
Annual DPS
$3.22
Quarterly DPS (est.)
~$0.80
Frequency
Quarterly
Annual Income / $10K
$215
Ex-dividend and payment dates are not available from SEC filings. Check your broker or the company's investor relations page for exact dates.
Yield History
Gilead Sciences (GILD) pays about $3.16 per share per year (a yield of roughly 2.2%), profiling as a safe dividend, modest income, with a payout streak of at least 10 years. The figures below are computed from SEC filings; this is analysis, not investment advice.
Yes, Gilead Sciences pays a regular dividend of about $3.16 per share per year (a yield of roughly 2.2%), typically in quarterly installments. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.
SourceDividend analysis computed from the 10-Q filed 6 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 19 Sept 2026. How this is calculated.
Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.
Gilead Sciences's dividend looks comfortably covered by free cash flow, with free cash flow covering the payout about 3.2 times over. Intrinsiqq scores its dividend safety at 90 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.
Gilead Sciences has raised its dividend for at least 10 years in a row, the full span of the dividend history we hold. Over the past five years the dividend has grown at roughly 3.0% a year. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.